People · Operator
Named in public records as an officer, director or promoter · active 2010–2026 · Healthtech, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Auris Health, Inc. | — | Healthtech | Series D+ | $718.1M | $5.3B | 2014 |
| Insightec Ltd | — | Healthtech | Series D+ | $436.4M | $1.6B | 2020 |
| ShockWave Medical, Inc. | — | Healthtech | Series C | $144.8M | $255.8M | 2015 |
| Avail Medsystems, Inc. | — | Other Health Care | Series C | $126.7M | $2.2B | 2020 |
| Intersect ENT, Inc. | — | Other Health Care | Series B | $85.7M | $462.2M | 2010 |
| G.I. Windows, Inc. | — | Biotechnology | Series B | $76.9M | $218.3M | 2017 |
| Potrero Medical, Inc. | — | Biotechnology | Series B | $76.2M | $9.9M | 2019 |
| SS Innovations International, Inc. | — | Biotechnology | Series B | $21.8M | $64.6M | 2026 |
Frederic H. Moll at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Frederic H. Moll on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Frederic Moll | 3 | 10 |
| Peter Hebert | 2 | 7 |
| Jay Watkins | 2 | 6 |
| Daniel Hawkins | 2 | 4 |
| Jay H. Watkins | 2 | 2 |
| Carter Meyer | 1 | 14 |
| Ajay Royan | 1 | 13 |
| David Greenberg | 1 | 13 |
| Daniel Burnett | 1 | 11 |
| James Wright | 1 | 9 |
| Christopher Thompson | 1 | 8 |
| FRED MOLL | 1 | 8 |
| Dana G. Mead, Jr. | 1 | 7 |
| David Neustaedter | 1 | 7 |
| ANTOINE PAPIERNIK | 1 | 6 |
| Marc-Andre Marcotte | 1 | 6 |
| Bijan Salehizadeh | 1 | 5 |
| Alan Chesler | 1 | 5 |
| Evan S. Melrose | 1 | 5 |
| Andrew ` Offer | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.